Archive: 01/10/2018

New drug approved for antibiotic-resistant lung disease

(HealthDay)—Arikayce has been approved by the U.S. Food and Drug Administration to treat lung disease caused by Mycobacterium avium complex (MAC) bacteria among people who don't respond to conventional therapies, the FDA ...

New treatment approved for common skin cancer

(HealthDay)—Libtayo (cemiplimab-rwlc) injection has been approved by the U.S. Food and Drug Administration to treat advanced squamous cell carcinoma (CSCC), the agency said in a news release.

Medicare upgrades its website ahead of sign-up season

Approaching annual sign-up season, Medicare is modernizing its website to make it more useful for beneficiaries already accustomed to searching online for insurers, hospitals and doctors, officials announced on Monday.

page 2 from 11